Chronic oxidative stress as a mechanism for radiation nephropathy

Radiation Research

Volumn 171, Issue 2, 2009, Pages 164-172

  Lenarczyk, Marek ^a   Cohen, Eric P ^a   Fish, Brian L ^a   Irving, Amy A ^a,b   Sharma, Mukut ^a   Driscoll, Collin D ^a,c   Moulder, John E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; DNA MARKER; GUANOSINE; METHANEARSONATE DISODIUM; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; IN VIVO STUDY; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION NEPHROPATHY; RAT; WHOLE BODY RADIATION;

ANIMALS; BLOOD UREA NITROGEN; BONE MARROW TRANSPLANTATION; DEOXYGUANOSINE; DINOPROST; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MODELS, ANIMAL; OXIDATIVE STRESS; RATS; WHOLE-BODY IRRADIATION;

ANIMALIA; RATTUS;

EID: 59649097666     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1454.1     Document Type: Article

References (49)

1. E. P. Cohen, A. A. Irving, W. R. Drobyski, J. P. Klein, J. Passweg, J. Talano, M. Juckett and J. E. Moulder, Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int. J. Radiat. Oncol. Biol. Phys. 70, 1546-1551 (2008).
2. T. Oikawa, M. Freeman, W. Lo, D. E. Vaughan and A. Fogo, Mod ulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int. 51, 164-172 (1997).
3. L. I. Juncos, S. Carrasco Dueñas, J. C. Cornejo, C. A. Broglia and H. Cejas, Long-term enalapril and hydrochlorothiazide in radiation nephritis. Nephron 64, 249-255 (1993).
4. J. E. Moulder, B. L. Fish and E. P. Cohen, ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy. Curr. Pharm. Design 9, 737-749 (2003).
5. J. E. Moulder, B. L. Fish and E. P. Cohen, Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists. Curr. Pharm. Design 13, 1317-1325 (2007).
6. J. E. Moulder and E. P. Cohen, Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin. Radiat. Oncol. 17, 141-148 (2007).
7. M. E. Robbins and D. I. Diz, Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int. J. Radiat. Oncol. Biol. Phys. 64, 6-12 (2006).
8. W. Zhao, D. I. Diz and M. E. Robbins, Oxidative damage pathways in relation to normal tissue injury. Br. J. Radiol. 80, S23-S31 (2007).
9. J. Kumagai, K. Masui, Y. Itagaki, M. Shiotani, S. Kodama, M. Watanabe and T. Miyazaki, Long-lived mutagenic radicals induced in mammalian cells by ionizing radiation are mainly localized to proteins. Radiat. Res. 160, 95-102 (2003).
10. H. Tominaga, S. Kodama, N. Matsuda, K. Suzuki and M. Watanabe, Involvement of reactive oxygen species (ROS) in the induction of genetic instability by radiation. J. Radiat. Res. (Tokyo) 45, 181-188 (2004).
11. Z. B. Wang, Y. Q. Liu, Y. Zhang, Y. Li, X. X. An, H. Xu, Y. Guo, W. Jin, Z. J. Jiang and Y. F. Cui, Reactive oxygen species, but not mitochondrial membrane potential, is associated with radiation-induced apoptosis of AHH-1 human lymphoblastoid cells. Cell Biol. Int. 31, 1353-1358 (2007).
12. M. E. C. Robbins, W. L. Zhao, C. S. Davis, S. Toyokuni and S. M. Bonsib, Radiation-induced kidney injury: a role for chronic oxidative stress? Micron 33, 133-141 (2002).
13. P. K. Datta, J. E. Moulder, B. L. Fish, E. P. Cohen and E. A. Lianos, Induction of heme oxygenase-1 in radiation nephropathy: Role of angiotensin. Radiat. Res. 155, 734-739 (2001).
14. N. G. Abraham and A. Kappas, Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med. 39, 1-25 (2005).
15. J. E. Moulder and B. L. Fish, Late toxicity of total body irradiation with bone marrow transplantation in a rat model. Int. J. Radiat. Oncol. Biol. Phys. 16, 1501-1509 (1989).
16. E. P. Cohen, B. L. Fish and J. E. Moulder, The renin-angiotensin system in experimental radiation nephropathy. J. Lab. Clin. Med. 139, 251-257 (2002).
17. E. P. Cohen, B. L. Fish, M. Sharma, X. A. Li and J. E. Moulder, The role of the angiotensin II type-2 receptor in radiation nephropathy. Transl. Res. 150, 106-115 (2007).
18. J. E. Moulder, Post-irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review. Int. J. Radiat. Biol. 80, 3-10 (2004).
19. J. E. Moulder, B. L. Fish and E. P. Cohen, Brief pharmacologic intervention in experimental radiation nephropathy. Radiat. Res. 150, 535-541 (1998).
20. E. P. Cohen, B. L. Fish and J. E. Moulder, Successful brief captopril treatment in radiation nephropathy. J. Lab. Clin. Med. 129, 536-547 (1997).
21. V. Witko-Sarsat, M. Friedlander, C. Capeillère-Blandin, T. Nguyen-Khoa, A. T. Nguyen, J. Zingraff, P. Jungers and B. Descamps-Latscha, Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49, 1304-1313 (1996).
22. P. S. Lim, Y. S. Ma, Y. M. Cheng, H. Chai, C. F. Lee, T. L. Chen and Y. H. Wei, Mitochondrial DNA mutations and oxidative damage in skeletal muscle of patients with chronic uremia. J. Biomed. Sci. 9, 549-560 (2002).
23. E. P. Cohen, J. E. Moulder, B. L. Fish and P. Hill, Prophylaxis of experimental bone marrow transplant nephropathy. J. Lab. Clin. Med. 124, 371-380 (1994).
24. T. Shimoike, T. Inoguchi, F. Umeda, H. Nawata, K. Kawano and H. Ochi, The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. Metab. Clin. Exp. 49, 1030-1035 (2000).
25. R. L. Levine, D. Garland, C. N. Oliver, A. Amici, I. Climent, A. G. Lenz, B. W. Ahn, S. Shaltiel and E. R. Stadtman, Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-478 (1990).
26. R. L. Levine, N. Wehr, J. A. Williams, E. R. Stadtman and E. Shacter, Determination of carbonyl groups in oxidized proteins. Methods Mol. Biol. 99, 15-24 (2000).
27. Y. Suzaki, Y. Ozawa and H. Kobori, Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats. Int. J. Biol. Sci. 3, 40-46 (2007).
28. Y. F. Wang, A. F. Chen and D. H. Wang, Enhanced oxidative stress in kidneys of salt-sensitive hypertension: Role of sensory nerves. Am. J. Physiol. 291, H3136-H3143 (2006).
29. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini and A. Milzani, Biomarkers of oxidative damage in human disease. Clin. Chem. 52, 601-623 (2006).
30. T. Hirai, K. Okumura, Y. Nishimoto, T. Shumiya, R. Murakami, R. Takahashi, T. Asai, H. Murakami, Y. Numaguchi and T. Murohara, Upregulation of renal eNOS by high-sodium diet facilitates hypertension in doxorubicin-treated rats through enhanced oxidative stress. Toxicology 225, 81-89 (2006).
31. H. Tsukahara, M. Hiraoka, R. Kobata, I. Hata, Y. Ohshima, M. Z. Jiang, E. Noiri and M. Mayumi, Increased oxidative stress in rats with chronic nitric oxide depletion: measurement of urinary 8-hy-droxy-2′-deoxyguanosine excretion. Redox Rep. 5, 23-28 (2000).
32. B. Halliwell and M. Whiteman, Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142, 231-255 (2004).
33. M. B. Kadiiska, B. C. Gladen, D. D. Baird, D. Germolec, L. B. Graham, C. E. Parker, A. Nyska, J. T. Wachsman, B. N. Ames and J. C. Barrett, Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic. Biol. Med. 38, 698-710 (2005).
34. J. Frank, H. K. Biesalski, S. Dominici and A. Pompella, The visualization of oxidant stress in tissues and isolated cells. Histol. Histopathol. 15, 173-184 (2000).
35. E. N. Haugen, A. J. Croatt and K. A. Nath, Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int. 58, 144-152 (2000).
36. N. A. G. Santos, C. S. Catão, N. M. Martins, C. Curti, M. L. P Bianchi and A. C. Santos, Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch. Toxicol. 81, 495-504 (2007).
37. A. P. Zou, N. Li and A. W. Cowley, Production and actions of superoxide in the renal medulla. Hypertension 37, 547-553 (2001).
38. Z. Zhang, N. I. Dmitrieva, J. H. Park, R. L. Levine and M. B. Burg, High urea and NaCl carbonylate proteins in renal cells in culture and in vivo, and high urea causes 8-oxoguanine lesions in their DNA. Proc. Natl. Acad. Sci. USA 101, 9491-9496 (2004).
39. A. Makino, M. M. Skelton, A. P. Zou, R. J. Roman and A. W. Cowley, Increased renal medullary oxidative stress produces hypertension. Hypertension 39, 667-672 (2002).
40. M. E. C. Robbins and W. Zhao, Chronic oxidative stress and radiation-induced late normal tissue injury: A review. Int. J. Radiat. Biol. 80, 251-259 (2004).
41. T. Grune and M. M. Berger, Markers of oxidative stress in ICU clinical settings: present and future. Cur. Opin. Clin. Nutr. Metab. Care 10, 712-717 (2007).
42. X. S. Wan, Z. Zhou, J. H. Ware and A. R. Kennedy, Standardization of a fluorometric assay for measuring oxidative stress in irradiated cells. Radiat. Res. 163, 232-240 (2005).
43. T. England, E. Beatty, A. Rehman, J. Nourooz-Zadeh, P. Pereira, J. O'Reilly, H. Wiseman, C. Geissler and B. Halliwell, The steady-state levels of oxidative DNA damage and of lipid peroxidation (F-2-isoprostanes) are not correlated in healthy human subjects. Free Radic. Res. 32, 355-362 (2000).
44. M. H. Lee, D. H. Hyun, P. Jenner and B. Halliwell, Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J. Neurochem. 78, 32-41 (2001).
45. P. Mecocci, G. Fanó, S. Fulle, U. MacGarvey, L. Shinobu, M. C. Polidori, A. Cherubini, J. Vecchiet, U. Senin and M. F. Beal, Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radic. Biol. Med. 26, 303-308 (1999).
46. T. Grune, T. Reinheckel and K. J. Davies, Degradation of oxidized proteins in mammalian cells. FASEB J. 11, 526-534 (1997).
47. H. Zhou, A. Kato, T. Miyaji, H. Yasuda, Y. Fujigaki, T. Yamamoto, K. Yonemura, S. Takebayashi, H. Mineta and A. Hishida, Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats. Nephrol. Dial. Transplant. 21, 616-623 (2006).
48. G. Aldini, I. Dalle-Donne, R. M. Facino, A. Milzani and M. Carini, Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med. Res. Rev. 27, 817-868 (2007).
49. S. Prabhakar, J. Starnes, S. Shi, B. Lonis and R. Tran, Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J. Am. Soc. Nephrol. 18, 2945-2952 (2007).